Clinical trial

Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer

NCT00491699

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2007-08-01

PhasePHASE1

Study timeline

Study start (unknown)2007-08-01Date precision: month

Registry last updated2010-02-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small-Cell Lung Cancerunresolved

Interventions

XL999DRUG

Sponsors & collaborators

Symphony Evolution, Inc.lead sponsor

Mapped research locations

Los AngelesCalifornia, United States1 AtlantaGeorgia, United States1 San AntonioTexas, United States1 DetroitMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00491699 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.